Terms: = Kidney tumors AND TPM3, ENSG00000143549, 7170
21 results:
1. Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging and Venous Tumor Thrombus Consistency in Renal Cell Carcinoma.
Zhao J; Wang M; Ding X; Fu Y; Peng C; Kang H; Guo H; Bai X; Huang Q; Zhou S; Zhang X; Liu K; Li L; Ye H; Zhang X; Ma X; Wang H
J Magn Reson Imaging; 2024 Jan; 59(1):134-145. PubMed ID: 37134147
[TBL] [Abstract] [Full Text] [Related]
2. Quantitative MRI in distinguishing bladder paraganglioma from bladder leiomyoma.
Hu X; Wang K; Sun M; Li C; Wang H; Guan J
Abdom Radiol (NY); 2023 Mar; 48(3):1051-1061. PubMed ID: 36690715
[TBL] [Abstract] [Full Text] [Related]
3. ALK-rearranged renal cell carcinoma with tpm3::ALK gene fusion and review of the literature.
Galea LA; Hildebrand MS; Witkowski T; Joy C; McEvoy CR; Hanegbi U; Aga A
Virchows Arch; 2023 Mar; 482(3):625-633. PubMed ID: 36370168
[TBL] [Abstract] [Full Text] [Related]
4. ALK rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report.
Kai K; Tobu S; Kido S; Mikami S; Takeuchi K; Dobashi A; Togashi Y; Noguchi M; Aishima S
Diagn Pathol; 2022 Jun; 17(1):52. PubMed ID: 35718773
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological characteristics of NTRK-rearranged mesenchymal tumors in childhood].
Yin MZ; Ma J; He Q; Shen P; Chen JF; Jin XT; Zhang ZD; Kuick CH; Chen HY; Ng EHQ; Aw SJ; Chang KTE
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):675-680. PubMed ID: 32610377
[No Abstract] [Full Text] [Related]
6. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
[TBL] [Abstract] [Full Text] [Related]
7. Diffusion-weighted MRI in the assessment of nephroblastoma: results of a multi-center trial.
Hötker AM; Lollert A; Mazaheri Y; Müller S; Schenk JP; Mildenberger PC; Akin O; Graf N; Staatz G
Abdom Radiol (NY); 2020 Oct; 45(10):3202-3212. PubMed ID: 32166338
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics of Renal Cell Carcinoma Harboring
Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
[TBL] [Abstract] [Full Text] [Related]
9. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
Hang JF; Chung HJ; Pan CC
Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
[TBL] [Abstract] [Full Text] [Related]
10. ALK-tpm3 rearrangement in adult renal cell carcinoma: a case report and literature review.
Yang J; Dong L; Du H; Li XB; Liang YX; Liu GR
Diagn Pathol; 2019 Oct; 14(1):112. PubMed ID: 31627758
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of prognostic nomograms for patients with metastatic prostate cancer.
Jiang WD; Yuan PC
Int Urol Nephrol; 2019 Oct; 51(10):1743-1753. PubMed ID: 31289983
[TBL] [Abstract] [Full Text] [Related]
12. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
[TBL] [Abstract] [Full Text] [Related]
13. ALK-tpm3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.
Bodokh Y; Ambrosetti D; Kubiniek V; Tibi B; Durand M; Amiel J; Pertuit M; Barlier A; Pedeutour F
Cancer Genet; 2018 Feb; 221():31-37. PubMed ID: 29405994
[TBL] [Abstract] [Full Text] [Related]
14. A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Daa T; Watanabe D; Akita Y; Sato F; Mimata H; Yokoyama S
Pathol Int; 2017 Dec; 67(12):626-631. PubMed ID: 29024210
[TBL] [Abstract] [Full Text] [Related]
15. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
Histopathology; 2017 Jul; 71(1):53-62. PubMed ID: 28199742
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
Seo AN; Yoon G; Ro JY
Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
[TBL] [Abstract] [Full Text] [Related]
17. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a tpm3-ALK translocation.
Thorner PS; Shago M; Marrano P; Shaikh F; Somers GR
Pathol Res Pract; 2016 Oct; 212(10):937-942. PubMed ID: 27450657
[TBL] [Abstract] [Full Text] [Related]
18. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract] [Full Text] [Related]
19. ALK-rearranged renal cell carcinomas in children.
Cajaiba MM; Jennings LJ; Rohan SM; Perez-Atayde AR; Marino-Enriquez A; Fletcher JA; Geller JI; Leuer KM; Bridge JA; Perlman EJ
Genes Chromosomes Cancer; 2016 May; 55(5):442-51. PubMed ID: 26773439
[TBL] [Abstract] [Full Text] [Related]
20. Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.
Sugawara E; Togashi Y; Kuroda N; Sakata S; Hatano S; Asaka R; Yuasa T; Yonese J; Kitagawa M; Mano H; Ishikawa Y; Takeuchi K
Cancer; 2012 Sep; 118(18):4427-36. PubMed ID: 22252991
[TBL] [Abstract] [Full Text] [Related]
[Next]
